SynthesisThe clinical respiratory journal2024

Which Is More Suitable for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer, PD-L1 Inhibitors Versus PD-1 Inhibitors? A Systematic Review and Network Meta-Analysis.

Wenjing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.